nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anthracycline dose intensification in young adults with acute myeloid leukemia
|
Padron, Eric |
|
2012 |
|
1 |
p. 17-27 |
artikel |
2 |
An update on the role of daratumumab in the treatment of multiple myeloma
|
Costello, Caitlin |
|
2017 |
|
1 |
p. 28-37 |
artikel |
3 |
Bosutinib in the treatment of patients with Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia: an overview
|
Shen, Ann Q. |
|
2014 |
|
1 |
p. 13-17 |
artikel |
4 |
Current challenges and novel treatment strategies in double hit lymphomas
|
Anderson, Mary Ann |
|
2016 |
|
1 |
p. 52-64 |
artikel |
5 |
Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians
|
Farruggia, Piero |
|
2015 |
|
1 |
p. 15-24 |
artikel |
6 |
Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma
|
Sethi, Tarsheen |
|
2017 |
|
1 |
p. 13-20 |
artikel |
7 |
Editorial
|
Mauro, Michael J. |
|
2012 |
|
1 |
p. 3-3 |
artikel |
8 |
Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia
|
Itchaki, Gilad |
|
2018 |
|
1 |
p. 3-19 |
artikel |
9 |
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib
|
Ailawadhi, Sikander |
|
2017 |
|
1 |
p. 3-12 |
artikel |
10 |
Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature
|
Pathak, Priyanka |
|
2014 |
|
1 |
p. 18-24 |
artikel |
11 |
Mantle cell lymphoma: observation to transplantation
|
Rajabi, Babak |
|
2015 |
|
1 |
p. 37-48 |
artikel |
12 |
Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies
|
Ommen, Hans Beier |
|
2016 |
|
1 |
p. 3-16 |
artikel |
13 |
New and emerging therapies for acute and chronic graft versus host disease
|
Hill, LaQuisa |
|
2018 |
|
1 |
p. 21-46 |
artikel |
14 |
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)
|
Ishii, Kazusa |
|
2016 |
|
1 |
p. 17-39 |
artikel |
15 |
Prevention and treatment of venous thromboembolism in patients with cancer
|
Hogg, Kerstin |
|
2012 |
|
1 |
p. 45-58 |
artikel |
16 |
Radiolabeled antibodies directed at CD45 for conditioning prior to allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome
|
Orozco, Johnnie J. |
|
2012 |
|
1 |
p. 5-16 |
artikel |
17 |
Regulatory T-cell immunotherapy for allogeneic hematopoietic stem-cell transplantation
|
Horch, Matthew |
|
2012 |
|
1 |
p. 29-44 |
artikel |
18 |
Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers
|
Wildes, Tanya M. |
|
2014 |
|
1 |
p. 3-12 |
artikel |
19 |
Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes
|
Navada, Shyamala C. |
|
2017 |
|
1 |
p. 21-27 |
artikel |
20 |
Targeting the leukemia–stroma interaction in acute myeloid leukemia: rationale and latest evidence
|
Rashidi, Armin |
|
2016 |
|
1 |
p. 40-51 |
artikel |
21 |
The biology behind PI3K inhibition in chronic lymphocytic leukaemia
|
Ortiz-Maldonado, Valentín |
|
2015 |
|
1 |
p. 25-36 |
artikel |
22 |
The importance of hematopoietic progenitor cells in dengue
|
Tsai, Jih-Jin |
|
2012 |
|
1 |
p. 59-71 |
artikel |
23 |
The role of observational studies in optimizing the clinical management of chronic myeloid leukemia
|
Mauro, Michael J. |
|
2015 |
|
1 |
p. 3-14 |
artikel |